Samsung Biologics Co.,Ltd.

207940.KS·KSE·Healthcare
Compare
1,520,000.00+25,000.00 (+1.67%)today
At close: Nov 5, 3:30 PM KST · May be delayed up to 20 min · KRW

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,495,000.00
Open1,539,000.00
Day range1,512,000.001,575,000.00
52-week range1,150,000.001,987,000.00
Off day high−3.49%
Off 52-week high−23.50%
Volume87.47K
Avg. volume (3M)57.38K
Market cap70.76T
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.15
Shares outstanding46.55M
Short interest—
Earnings dateOct 21, 2026 (est.)
Analyst target1,879,148.10
Profit margin38.75%

Against its peers

Compare in full ›
207940.KS 085660.KQ 302440.KS 214450.KQ BIOCON.NS 005690.KS
Market cap 70.76T 677.77B 2.90T 2.34T 592.87B 522.03B
P/E (TTM) — — — — 121.5 —
Forward P/E — — — — 33.3 —
Price/book — — — — 1.7 —
Dividend yield — — — 1.66% 0.15% 0.55%
1-year change −20.37% −45.74% −40.00% −56.00% −10.58% −50.06%
Today +1.67% +5.96% +7.10% +0.67% +5.10% −3.76%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

The Asia Business Daily··3 outletsPositive

Samsung Biologics Earns Top Rating in ESG Risk Assessment

Published 04 Nov.2026 08:51(KST) Samsung Biologics received the highest rating in a global environmental, social and governance (ESG) risk assessment. A view of Samsung Biologics Plant 4 in Songdo, Yeonsu-gu, Incheon. Samsung Biologics. On…

More from 2 other outlets
Korea Biomedical Review·Positive

Samsung Biologics shares up 1.7% after $325 mil. CMO deal

Korea Biomedical Review Samsung Biologics shares rose 1.69 percent on Tuesday after the company said it signed a $324.8 million contract manufacturing organization (CMO) deal with a global pharmaceutical company. The stock traded at…

From the 4Search news index, newest first.

In the news

49mentions in 30 days
49with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 49 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance